Recovering autonomy is a key advantage of home-based immunoglobulin therapy in patients with myositis: A qualitative research study

Immunoglobulins are 2nd or 3rd-line treatments in dermatomyositis (DM) or polymyositis (PM) refractory to high-dose corticosteroids and immunosuppressants. Immunoglobulins (2 g/kg/mo) are usually administered intravenously (IVIg) once a month and the patients stay at hospital for a few days. Recentl...

Descripción completa

Detalles Bibliográficos
Autores principales: Chérin, Patrick, Pindi Sala, Taylor, Clerson, Pierre, Dokhan, Annaïk, Fardini, Yann, Duracinsky, Martin, Crave, Jean-Charles, Chassany, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
3600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035045/
https://www.ncbi.nlm.nih.gov/pubmed/32049796
http://dx.doi.org/10.1097/MD.0000000000019012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035045/
https://www.ncbi.nlm.nih.gov/pubmed/32049796
http://dx.doi.org/10.1097/MD.0000000000019012

Ejemplares similares